Gale Rp
About
In The Last Decade
Gale Rp
167 papers receiving 10.5k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Hematology 8.5k
- Immunology 3.2k
- Oncology 2.8k
- Public Health, Environmental and Occupational Health 2.4k
- Genetics 2.2k
Countries citing papers authored by Gale Rp
This map shows the geographic impact of Gale Rp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gale Rp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gale Rp more than expected).
Fields of papers citing papers by Gale Rp
This network shows the impact of papers produced by Gale Rp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gale Rp. The network helps show where Gale Rp may publish in the future.
Co-authorship network of co-authors of Gale Rp
This figure shows the co-authorship network connecting the top 25 collaborators of Gale Rp. A scholar is included among the top collaborators of Gale Rp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gale Rp. Gale Rp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 53 | |
| 3 | 25 | |
| 4 | 152 | |
| 5 | 35 | |
| 6 | 41 | |
| 7 | 6 | |
| 8 | Living with "agency ulcers": lessons from the USDA Forest Service. | 1 |
| 9 | Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. breakdown → | 617 |
| 10 | Chemotherapy versus transplantation: I. Acute myelogenous leukemia. | 5 |
| 11 | Acute lymphoblastic leukemia: current controversies, future directions. | 1 |
| 12 | Clinical uses of intravenous immunoglobulins. | 40 |
| 13 | Graft-vs-leukemia following bone marrow transplantation: a model of immunotherapy in man. | 3 |
| 14 | Fetal liver transplantation in hematologic disorders. | 6 |
| 15 | Current status of bone marrow transplantation in acute leukemia. | 7 |
| 16 | Isolation, cryopreservation, and autotransplantation of human stem cells. | 17 |
| 17 | Significance of HLA and non-HLA antigens in bone marrow transplantation. | 6 |
| 18 | Antitumor activity of some amino acid metal systems. | 1 |
| 19 | 15 | |
| 20 | Bone marrow transplantation in acute leukemia using intensive chemoradiotherapy (SCARI--UCLA). | 12 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.